Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster

Схожие документы

• Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign
  по: Wambier, Carlos Gustavo, et al.
  Опубликовано: (2020)
• What does androgenetic alopecia have to do with COVID‐19? An insight into a potential new therapy
  по: Goren, Andy, et al.
  Опубликовано: (2020)
• Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
  по: Wambier, Carlos Gustavo, et al.
  Опубликовано: (2020)
• Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19?
  по: McCoy, John, et al.
  Опубликовано: (2020)
• Reply to: “Comment on ‘Androgenetic alopecia present in the majority of patients hospitalized with COVID-19’”
  по: Wambier, Carlos G.
  Опубликовано: (2021)